Evidence map›Paper›PMID 41807955›Full record

ArticlePediatric rheumatology online journal2026

Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children.

Chloe Bianchi, Isabelle Melki, Vanja Sisirak, Severine Loizon, Martin Broly, Guilaine Boursier, Maud Tusseau, Audrey Laurent, Alexandre Belot, Laurence Eitenschenck and 6 more

Abstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chloe BianchiPediatric Department, Pellegrin Hospital, Centre de Référence Maladies Rares des Rhumatismes inflammatoires et maladies Auto-immunes et Interféronopathies Systémiques rares de l'Enfant (RAISE), INSERM CICP, University Hospital Centre of Bordeaux, Bordeaux, CIC1401, France.
Isabelle MelkiDepartment of General Pediatrics, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Paris, France.
Vanja SisirakCNRS UMR5164 ImmunoConcEpT, University of Bordeaux, Bordeaux, France.
Severine LoizonCNRS UMR5164 ImmunoConcEpT, University of Bordeaux, Bordeaux, France.
Martin BrolyLaboratory of Genetics of Rare and Autoinflammatory Diseases, Department of Molecular Genetics and Cytogenomics, National Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Montpellier University Hospital, Montpellier, France.
Guilaine BoursierLaboratory of Genetics of Rare and Autoinflammatory Diseases, Department of Molecular Genetics and Cytogenomics, National Reference Center for Autoinflammatory Diseases and AA Amyloidosis, Montpellier University Hospital, Montpellier, France.
Maud TusseauCentre International de Recherche en Infectiologie, University Claude Bernard, Centre National de La Recherche Scientifique, UMR5308, ENS de Lyon, Lyon 1, Inserm, Lyon, U1111, France.
Audrey LaurentPediatric Nephrology, Rheumatology, Dermatology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.
Alexandre BelotPediatric Nephrology, Rheumatology, Dermatology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France.
Laurence EitenschenckPediatric Department, Annecy Hospital, Annecy, France.
Vincent GuigonisPediatric Department, Limoges University Hospital, Limoges, France.
Eric JeziorskiPediatric Department, Montpellier University Hospital, Montpellier, France.
Damia LeguevaquesPediatric Department, Lille University Hospital, Lille, France.
Olivier RicherPediatric Department, Pellegrin Hospital, Centre de Référence Maladies Rares des Rhumatismes inflammatoires et maladies Auto-immunes et Interféronopathies Systémiques rares de l'Enfant (RAISE), INSERM CICP, University Hospital Centre of Bordeaux, Bordeaux, CIC1401, France.
Pascal PilletPediatric Department, Pellegrin Hospital, Centre de Référence Maladies Rares des Rhumatismes inflammatoires et maladies Auto-immunes et Interféronopathies Systémiques rares de l'Enfant (RAISE), INSERM CICP, University Hospital Centre of Bordeaux, Bordeaux, CIC1401, France.
Jérôme GranelPediatric Department, Pellegrin Hospital, Centre de Référence Maladies Rares des Rhumatismes inflammatoires et maladies Auto-immunes et Interféronopathies Systémiques rares de l'Enfant (RAISE), INSERM CICP, University Hospital Centre of Bordeaux, Bordeaux, CIC1401, France. jerome.granel@chu-bordeaux.fr.ORCID http://orcid.org/0000-0002-4470-1023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHypocomplementaemic urticarial vasculitis (HUV) is a rare small-vessel vasculitis characterized by the combination of urticarial vasculitis and hypocomplementaemia. HUV may occur in isolation or be associated with systemic diseases such as systemic lupus erythematosus (SLE). Recently, loss-of-function variants in DNASE1L3 have been reported to cause familial forms of HUV. We aimed to describe the clinical and genetic features of childhood-onset HUV cases in France.

methodsWe conducted a nationwide retrospective study in France that included 10 patients with childhood-onset HUV.

resultsTen children, all girls, were included. Their median age at onset was 9.5 years (range: 2–14 years), and the median delay between onset and diagnosis was 13 months (range: 6–55 months). Phenotypes were heterogeneous: 3 had systemic HUV syndrome (S-HUVS), all associated with DNASE1L3 deficiency, including 2 siblings; 4 had non-systemic HUVS (NS-HUVS), one of whom had a C2 deficiency; and 3 had SLE-associated HUV. Musculoskeletal features were the most common extracutaneous manifestation (9/10). The most severe manifestations were observed in children with S-HUVS, including pulmonary haemorrhage (2/3) and glomerulonephritis (2/3). Anti-nuclear antibodies were positive in 9/10 patients, anti-C1q antibodies in 6/10, and anti-neutrophil cytoplasmic antibodies in 5/10. Antihistamines were widely used in NS-HUVS, while S-HUVS and SLE-associated HUV required immunosuppressive treatments. Hydroxychloroquine was used in 8/10 patients.

conclusionThese 10 cases highlight the heterogeneity and potential severity of childhood-onset HUV. We report the third familial form of HUVS associated with DNASE1L3 deficiency and an extremely rare case of HUVS associated with C2 deficiency.

Indexed as

UrticariaVasculitisAdolescentAge of OnsetChildChild, PreschoolEndodeoxyribonucleasesFemaleFranceGenotypeHumansLupus Erythematosus, SystemicPhenotypeRetrospective StudiesDNASE1L3 protein, humanEndodeoxyribonucleasesC2 deficiencyChildrenDNASE1L3 deficiencyHypocomplementaemic urticarial vasculitisMcDuffie syndromeSystemic lupus erythematous

Identifiers

PMID41807955
PMCPMC13067430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.